Sherwin-Williams director Thomas Williams reported a change in beneficial ownership tied to the company’s common stock on July 6, 2026, in a Form 4 filed July 8. The reported action was not an open-market stock purchase or sale, but an exempt acquisition of deferred stock units under Sherwin-Williams’ 2005 Director Deferred Fee Plan. The deferred stock units represent an economic interest equivalent to Sherwin-Williams common stock: each unit is the economic equivalent of one share of common stock. Under the plan, the units are payable solely in stock and generally become distributable after Williams separates from service as a director of the company. The filing notes that the number of units credited was determined using a weighted average share price on the July 6 transaction date, although the provided filing text does not show the actual number of deferred stock units acquired or the weighted average price. The filing also clarifies the composition of Williams’ reported holdings. One category of securities consists of deferred stock units held under the Director Deferred Fee Plan, including additional units acquired through the plan’s dividend reinvestment feature. Another reported position consists of 1,334 restricted stock units and 1,037 shares of Sherwin-Williams common stock. Each restricted stock unit represents the right to receive one share of common stock. A separate line in the filing is described as not reporting a new transaction and instead reflecting securities previously reported on an earlier Form 4. No transaction code is visible in the provided document text, but the notes identify the July 6 activity as an exempt transaction under the deferred fee plan. The filing was signed on Williams’ behalf by Stephen J. Perisutti as attorney-in-fact.